Myofilament-level effects of aficamten increase diastolic chamber volumes and maintain cardiac output through preserved length-dependent force generation in healthy rat and canine myocardium - Summary - MDSpire

Myofilament-level effects of aficamten increase diastolic chamber volumes and maintain cardiac output through preserved length-dependent force generation in healthy rat and canine myocardium

  • By

  • Fruzsina Sárkány

  • Dániel Priksz

  • Béla Juhász

  • László Ádám Fazekas

  • Norbert Németh

  • Norbert Szentandrássy

  • Balázs Horváth

  • Zsigmond Máté Kovács

  • Attila Borbély

  • Arnold Péter Ráduly

  • Attila Tóth

  • Miklós Fagyas

  • Beáta Bódi

  • Zoltán Papp

  • June 26, 2026

  • 0 min

Share

Objective:

To investigate the interaction between aficamten-induced myosin inhibition and the major regulators of myocardial contractile function in rat and canine hearts.

Approach:
  • Animal Models: In vivo experiments were conducted using adult male Wistar rats and mongrel dogs to assess the effects of aficamten on cardiac performance.
  • Echocardiography: Transthoracic echocardiography was performed during intracardiac pacing to evaluate cardiac function under varying conditions.
Key Findings:
  • Aficamten demonstrated favorable effects on diastolic function and cardiac output despite its inhibitory action on myosin.
  • The study identified key determinants of systolic and diastolic performance in the context of myosin inhibition.
Interpretation:

The findings provide mechanistic insight into how aficamten may preserve cardiac output, informing the physiological basis for its therapeutic application.

Limitations:
  • The applicability of results to human subjects requires further randomized trials.
  • The study primarily focused on animal models, which may not fully replicate human physiology.
Conclusion:

Aficamten's myofilament-level impact may enhance diastolic chamber volumes and sustain cardiac output through preserved length-dependent force generation.

Original Source(s)

Myofilament-level effects of aficamten increase diastolic chamber volumes and maintain cardiac output through preserved length-dependent force generation in healthy rat and canine myocardium

  • by Fruzsina Sárkány, Dániel Priksz, Béla Juhász, László Ádám Fazekas, Norbert Németh, Norbert Szentandrássy, Balázs Horváth, Zsigmond Máté Kovács, Attila Borbély, Arnold Péter Ráduly, Attila Tóth, Miklós Fagyas, Beáta Bódi, Zoltán Papp

  • June 26, 2026

Related Content

Incidence of delirium in hospitalized heart failure patients: a systematic review and meta-analysis

High-density lipoprotein cholesterol levels and prognosis in non-ischemic dilated cardiomyopathy

Does Mitral Regurgitation Mechanism Matter After M-TEER?

Left ventricular diameter changes were similar across subtypes at 1 month, while pulmonary artery systolic pressure responses differed by mechanism.